Life Sciences
Breakthroughs happen with Cooley
Advancing life sciences through unrivaled experience and industry relationships. With Cooley as your catalyst, you’re not just part of the life sciences industry – you’re shaping it.
Why Cooley
-
Unmatched industry experience
Since incorporating the first-ever biotech company, Genentech, in 1976, Cooley has remained at the forefront of life sciences
-
Support across the full life cycle
We represent innovative companies at every stage – from disruptive startups to global public companies across the biotech, pharmaceutical, medtech, diagnostics and digital health services industries
-
Market-leading deal volume
We consistently lead in life sciences venture financings, initial public offerings (IPOs) and M&A, advising on hundreds of deals annually and helping our clients raise billions in capital
-
Legal partner to industry innovators
Life sciences companies of all sizes turn to Cooley for strategic legal counsel that fuels innovation, supports growth and drives long-term success
Practices
-
2,500+public and private life sciences and healthcare company clients worldwide500+timekeepers that devote half or more of their billable hours to life sciences clients#1for healthcare and life sciences initial public offerings since 2016 – Deal Point Data#1firm for pharma and biotech VC deals – PitchBook Annual Global League Tables, FY 2025#1in life sciences M&A by deal count in the US and globally – Bloomberg, H1 202540+dedicated international professionals across the US, Europe and Asia exclusively focused on life sciences commercial transactionsTier 1for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas
Cooley Rx
This virtual series focuses on the top issues and trends in the life sciences and healthcare industries – and provides decision-makers with information they can use to strengthen their organizations
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
LMG Life Sciences
Life Sciences Resources
From startup to scale, our industry resources equip life sciences leaders with curated insights on regulatory developments, financing trends, IP strategies and key legal considerations shaping the life sciences landscape
Recognitions
- Chambers USA: Band 1 for Life Sciences (Nationwide, California, Massachusetts)
- Chambers UK: Band 1 for Life Sciences: Transactional
- The Legal 500 US: Tier 1 for Healthcare – Life Sciences
- Law360: Life Sciences Practice Group of the Year (2022 – 2025)
- LMG Life Sciences Americas: Tier 1 in Corporate, Venture Capital, Licensing & Collaboration, Mergers & Acquisitions, Patent Strategy and Patent Prosecution
- LMG Life Sciences Americas: Corporate Firm of the Year (2023 – 2025)
- LMG Life Sciences Americas: Hatch-Waxman Litigation Firm of the Year (2025)
- LMG Life Sciences EMEA: Licensing and Collaboration Firm of the Year (2025)
- PitchBook: #1 firm for pharma and biotech VC deals by deal count (2025)
- Bloomberg: #1 for US and global life sciences M&A by deal count (H1 2025)
Group contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.